EV/EBITDA
28.90
-3.29-10.22%
19 min ago
Summary
- As of February 7, 2025, RIGL EV/EBITDA is 28.90, with a fall of -3.29 (-10.22%) during the most recent trading day.
- Over the past year, RIGL EV/EBITDA has increased by +42.07 (+319.44%).
- RIGL EV/EBITDA is now -21.57% below its all-time high of 36.85.
Performance
RIGL EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RIGL EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -10.2% | -10.2% | -10.4% |
| 1 m1 month | +32.0% | +32.0% | +33.0% |
| 3 m3 months | +32.0% | +31.9% | +32.9% |
| 6 m6 months | +171.7% | +98.8% | +121.4% |
| ytdytd | +28.4% | +28.5% | +29.3% |
| 1 y1 year | +319.4% | +76.6% | +95.9% |
| 5 y5 years | +574.5% | -1.6% | -4.6% |
RIGL EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.2% | 21.18 | +36.5% | |
| 3 m | 3-month | 36.85 | -21.6% | 21.13 | +36.8% |
| 6 m | 6-month | 36.85 | -21.6% | -63.59 | +145.4% |
| 1 y | 1-year | 36.85 | -21.6% | -63.59 | +145.4% |
| 3 y | 3-year | 36.85 | -21.6% | -63.59 | +145.4% |
| 5 y | 5-year | 36.85 | -21.6% | -242.79 | +111.9% |
| alltime | all time | 36.85 | -21.6% | -242.79 | +111.9% |
Rigel Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 28.90(+28.4%) |
| 2024 | 22.50(-235.8%) |
| 2023 | -16.57(+221.7%) |
| 2022 | -5.15(-87.5%) |
| 2021 | -41.32(+90.2%) |
| 2020 | -21.72(+283.1%) |
| 2019 | -5.67(+30.3%) |
| 2018 | -4.35(-36.5%) |
| 2017 | -6.85(+97.4%) |
| 2016 | -3.47(-24.4%) |
| 2015 | -4.59(+120.7%) |
| 2014 | -2.08(-22.4%) |
| 2013 | -2.68(-51.3%) |
| Date | Value |
|---|---|
| 2012 | -5.50(-15.1%) |
| 2011 | -6.48(-165.9%) |
| 2010 | 9.84(-325.2%) |
| 2009 | -4.37(+128.8%) |
| 2008 | -1.91(-80.2%) |
| 2007 | -9.64(+58.3%) |
| 2006 | -6.09(+114.4%) |
| 2005 | -2.84(-67.2%) |
| 2004 | -8.66(+17.0%) |
| 2003 | -7.40(+687.2%) |
| 2002 | -0.94(-90.0%) |
| 2001 | -9.41(-26.8%) |
| 2000 | -12.86 |
FAQ
- What is Rigel Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Rigel Pharmaceuticals?
- What is RIGL EV/EBITDA year-to-date change?
- What is Rigel Pharmaceuticals EV/EBITDA year-on-year change?
What is Rigel Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of RIGL is 28.90
What is the all time high EV/EBITDA for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high EV/EBITDA is 36.85
What is RIGL EV/EBITDA year-to-date change?
Rigel Pharmaceuticals EV/EBITDA has changed by +6.40 (+28.44%) since the beginning of the year
What is Rigel Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, RIGL EV/EBITDA has changed by +42.07 (+319.44%)